There were no reports of overdose during the clinical development program for Dapagliflozin. In the event of an overdose, contact the poison control center. It is also reasonable to employ supportive measures as dictated by the patient's clinical status. The removal of Dapagliflozin by hemodialysis has not been studied.
Sign Out
